MBOT Microbot Medical Inc

Price (delayed)

$1.31

Market cap

$87.99M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$85.45M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 8

Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed ...

Highlights
Microbot Medical's EPS has surged by 59% YoY and by 8% QoQ
Microbot Medical's debt has decreased by 2.4% from the previous quarter
The equity has soared by 127% YoY but it has decreased by 7% QoQ
MBOT's quick ratio is up by 47% YoY but it is down by 19% from the previous quarter
MBOT's net income is down by 29% year-on-year and by 15% since the previous quarter

Key stats

What are the main financial stats of MBOT

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
-5.07%
1 week
-9.03%
1 month
-12.67%
1 year
-62.36%
YTD
-34.5%
QTD
-32.82%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$346,000
Gross profit
-$641,000
Operating income
-$18.19M
Net income
-$16.34M
Gross margin
-185.3%
Net margin
-4,722.3%
Microbot Medical's net margin has soared by 65% from the previous quarter
MBOT's operating margin has surged by 65% since the previous quarter
MBOT's operating income is down by 35% year-on-year and by 16% since the previous quarter
MBOT's net income is down by 29% year-on-year and by 15% since the previous quarter

Price vs fundamentals

How does MBOT's price correlate with its fundamentals

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
1.28
P/S
254.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
246.96
Microbot Medical's EPS has surged by 59% YoY and by 8% QoQ
The equity has soared by 127% YoY but it has decreased by 7% QoQ
The stock's price to book (P/B) is 58% less than its 5-year quarterly average of 3.2 and 29% less than its last 4 quarters average of 1.9

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital has surged by 75% YoY
The ROE has soared by 71% YoY
MBOT's return on assets has surged by 69% year-on-year
Microbot Medical's return on sales has surged by 65% QoQ

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
The total assets has soared by 121% YoY but it fell by 6% QoQ
MBOT's total liabilities has surged by 60% year-on-year and by 12% since the previous quarter
Microbot Medical's debt is 99% less than its equity
The equity has soared by 127% YoY but it has decreased by 7% QoQ
Microbot Medical's debt has decreased by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.